1. Home
  2. LEVI vs ICLR Comparison

LEVI vs ICLR Comparison

Compare LEVI & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Levi Strauss & Co

LEVI

Levi Strauss & Co

HOLD

Current Price

$24.01

Market Cap

9.0B

ML Signal

HOLD

Logo ICON plc

ICLR

ICON plc

HOLD

Current Price

$146.18

Market Cap

9.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEVI
ICLR
Founded
1853
1990
Country
United States
Ireland
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Commercial Physical & Biological Resarch
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
9.3B
IPO Year
2019
2001

Fundamental Metrics

Financial Performance
Metric
LEVI
ICLR
Price
$24.01
$146.18
Analyst Decision
Strong Buy
Buy
Analyst Count
12
13
Target Price
$26.92
$178.62
AVG Volume (30 Days)
2.2M
1.1M
Earning Date
04-07-2026
05-12-2026
Dividend Yield
2.56%
N/A
EPS Growth
178.85
N/A
EPS
0.45
N/A
Revenue
$6,282,000,000.00
N/A
Revenue This Year
$8.64
N/A
Revenue Next Year
$4.82
N/A
P/E Ratio
$53.86
$12.91
Revenue Growth
N/A
N/A
52 Week Low
$16.95
$66.57
52 Week High
$24.82
$211.00

Technical Indicators

Market Signals
Indicator
LEVI
ICLR
Relative Strength Index (RSI) 63.29 63.32
Support Level $21.80 $99.11
Resistance Level $24.82 $188.03
Average True Range (ATR) 0.73 8.29
MACD 0.12 1.04
Stochastic Oscillator 87.33 77.73

Price Performance

Historical Comparison
LEVI
ICLR

About LEVI Levi Strauss & Co

Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver; Europe; and Asia.

About ICLR ICON plc

Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.

Share on Social Networks: